Source: Good News Network
An exciting new gene therapy trial has restored full or partial vision to blind patients who were robbed of their sight because of a genetic condition.
The study, which was launched at the University of Oxford back in 2011, recruited 14 patients to receive an eye injection of the virus containing the missing gene that caused the blindness.
By the end of the study, there was a significant gain in vision across the group of patients as a whole.
Furthermore, of the 12 patients who received the treatment without any complications, 100% either gained or maintained vision in their treated eyes, which was sustained for up to 5 years at the last follow-up. During this time, only 25% of the untreated eyes – which acted as a control group – maintained vision.
RELATED: After Century of Removing Appendixes, Docs Find Antibiotics Can Be Enough Two-Thirds of the Time
This was the world’s first gene therapy trial for…
The post In ‘World First,’ Gene Therapy Trial Restores Vision in Patients With Genetic Form of Blindness appeared first on FeedBox.